Hepatocellular carcinoma

Current Opinion in Gastroenterology

Volumn 17, Issue 3, 2001, Pages 276-280

  Chokshi, Manish M ^a   Marrero, Jorge A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; GEMCITABINE;

ANGIOGENESIS; CANCER DIAGNOSIS; CANCER SURVIVAL; CIGARETTE SMOKING; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; REVIEW; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

EID: 0035045702     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200105000-00011     Document Type: Review

References (48)

1. Rising incidence of hepatocellular carcinoma in the United States
2. The National Cancer Data Base report on treatment patterns for hepatocellular carcinoma
3. Tobacco smoking, alcohol consumption, and their interactions in the causation of HCC
4. Hepatocellular carcinoma occurring in non-fibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases
5. Hepatitis C-related cirrhosis: Time to occurrence of hepatocellular carcinoma and death
6. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C: A long-term follow-up study after histologic diagnosis
7. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
8. Screening for hepatocellular carcinoma in patients with advanced cirrhosis
9. Early detection of hepatocellular carcinoma increases the chance of treatment
10. A simultaneous monitoring of Lens culinari agglutinin A-reactive alpha-fetoprotein and des-carboxygamma prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients
11. Clinical applications of research on angiogenesis
12. Benign and malignant nodules in cirrhotic livers: Distinction based on blood supply
13. Hypervascular hepatocellular carcinoma: Evaluation of hemodynamics with dynamic CT during hepatic arteriography
14. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
15. Tumor angiogenesis: Past, present, and the near future
16. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis
17. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma
18. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues
19. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats
20. Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozigosity region of chromosome 8p23 in human hepatocellular carcinoma
21. p16 is a major inactivation target in hepatocellular carcinoma
22. The role of telomerase activity in hepatocellular carcinoma
23. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent
24. Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second-harmonic versus conventional power doppler US
25. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: Accuracy of helical CT in transplant patients
26. Focal liver lesions: Pattern-based classification scheme for enhancement at arterial phase CT
27. Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis
28. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions
29. Detection of hepatocellular carcinoma: Comparison of low- and high-spatial-resolution dynamic MR images
30. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group
31. Effectiveness of interferon therapy for reducing the incidence of hepatocellular carcinoma among patients with type C chronic hepatitis
32. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection
33. The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
34. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
35. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy
36. Small hepatocellular carcinoma: Safety and efficacy of single high-dose percutaneous acetic acid injection for treatment
37. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection
38. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: A validated prognostic model
39. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis
40. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions
41. Percutaneous radio-frequency thermal ablation of non-resectable hepatocellular carcinoma after occlusion of tumor blood supply
42. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
43. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success: Results from a liver transplantation center
44. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma
45. Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma
46. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
47. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis
48. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomized trial